Move beyond pilots and proofs-of-concept to AI systems that hold up in production — controlled, trusted, and adopted across your organization.
Most AI initiatives don't fail loudly. They fade quietly — through lack of trust, weak adoption, and systems no one actually uses.
In pharma R&D, successful AI systems are built on three things. Get one wrong and the system stalls — no matter how impressive the demo.
Systems behave predictably because data, tools, and workflows are intentionally designed — not left to a model's discretion.
Outputs are grounded, traceable, and defensible under audit — so people actually rely on them.
Teams actually use the system because it's reliable and aligned with how they already work.
When control, trust, or adoption is missing, it doesn't show up as an abstract risk. It shows up as a moment you recognize.
It answered instantly and sounded completely sure of itself — then cited a guideline that didn't exist.
When you can't trace an answer back to its source, you can't defend it. So you stop trusting any of it.
The pilot demo was brilliant. Six months later, it still wasn't anywhere near a validated process.
A system that behaves differently every run can't be validated — so it never makes it into the work that matters.
We bought the licenses and ran the training. Within a month the team had quietly gone back to doing it by hand.
A tool that doesn't fit how people actually work returns nothing — however advanced the model behind it is.
The platforms manage the systems. Your SOPs define the rules. Your methodologies define the process. But someone still has to determine what applies, what must be produced, and how the work should move forward — and today that work is manual, fragmented, and dependent on tribal knowledge. That's where Centrific operates.
What you're doing, and the conditions it runs under.
SOPs, methodologies, and policies — your real rules.
Controlled, traceable, and grounded in your sources.
Teams execute complex regulated work consistently, defensibly, and with far less manual effort.
Not a platform problem — a workflow problem. The platforms own the systems; Centrific turns your SOPs, methodologies, and policies into executable work.
AI systems rarely fail because the model isn't capable. They fail because the surrounding ecosystem — data, workflows, governance, evaluation, and organizational alignment — wasn't designed for production reality.
Poor data quality and fragmented knowledge sources create confident but unreliable outputs.
Deploying AI without redesigning workflows rarely creates lasting value.
When business, IT, and compliance move independently, initiatives stall or fragment into shadow AI.
Without clear controls, organizations introduce compliance, security, and operational risk.
Inconsistent or untraceable outputs quickly reduce adoption.
The organizations seeing meaningful value from AI are approaching it as a systems and workflow transformation challenge — not simply a technology rollout.
AI isn't magic. It's leverage — when applied intentionally.
AI strategy in pharma R&D requires more than model selection.
I've spent more than 25 years delivering enterprise systems in global pharma R&D across clinical, regulatory, safety, and operational domains.
Today, I focus on helping organizations navigate the realities of AI adoption in regulated environments — governance, trust, workflow integration, and systems designed to hold up under real-world scrutiny.
The organizations creating lasting value with AI are solving for control, trust, and adoption — not just technical capability. If you're exploring how AI could responsibly support your organization, I'd be happy to talk.